Cas:4314-19-6 Bis(1-benzotriazolyl)methanethione manufacturer & supplier

Chemical Name:Bis(1-benzotriazolyl)methanethione

CAS.NO:4314-19-6

Synonyms:bis(benzotriazol-1-yl)methanethione;bis(1H-benzotriazol-1-yl)methanethione;bis(benzotriazole)methanethione;bis(benzotriazolyl)methanethione;1,1′-(Thiocarbonyl)bis-1H-benzotriazole;MFCD00424275;BIS(1-BENZOTRIAZOLYL)METHANETHIONE 97;1,1′-Thiocarbonyldibenzotriazole

Molecular Formula:C₁₃H₈N₆S

Molecular Weight:280.30800

HS Code:2933990090

Physical and Chemical Properties:

Melting point:170-174ºC(lit.)

Boiling point:509.1ºC at 760 mmHg

Density:1.58g/cm3

Index of Refraction:1.859

PSA:93.51000

Exact Mass:280.05300

LogP:1.85730

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like bis(benzotriazol-1-yl)methanethione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1′-Thiocarbonyldibenzotriazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1′-Thiocarbonyldibenzotriazole Use and application,1,1′-(Thiocarbonyl)bis-1H-benzotriazole technical grade,usp/ep/jp grade.

Related News: Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. Bis(1-benzotriazolyl)methanethione manufacturer ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� Bis(1-benzotriazolyl)methanethione supplier Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. Bis(1-benzotriazolyl)methanethione vendor If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. Bis(1-benzotriazolyl)methanethione factory ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.��